Outcomes of Stereotactic Body Radiation in Pancreatic Cancer

被引：0
|
作者：
Park, Catherine [1 ]
Chuong, Michael [1 ]
Weber, Jill [1 ]
Springette, Gregory [1 ]
Hodul, Pamela [1 ]
Malafa, Mokenge [1 ]
Hoffe, Sarah [1 ]
Shridhar, Ravi [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2012年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [31] Stereotactic Body Radiation Therapy (SBRT) in Pancreatic Cancer: Is It Ready for Prime Time?
    Chang, Bryan W.
    Saif, Muhammad W.
    JOURNAL OF THE PANCREAS, 2008, 9 (06): : 676 - 682
  • [32] Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer
    Park, Joseph J.
    Hajj, Carla
    Reyngold, Marsha
    Shi, Weiji
    Zhang, Zhigang
    Cuaron, John J.
    Crane, Christopher H.
    O'Reilly, Eileen M.
    Lowery, Maeve A.
    Yu, Kenneth H.
    Goodman, Karyn A.
    Wu, Abraham J.
    ACTA ONCOLOGICA, 2017, 56 (12) : 1746 - 1753
  • [33] Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
    Sutera, Philip
    Bernard, Mark E.
    Wang, Hong
    Bahary, Nathan
    Burton, Steven
    Zeh, Herbert
    Heron, Dwight E.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [34] Clinical outcomes following stereotactic ablative body radiotherapy to inoperable pancreatic cancer
    Duong, J.
    Harrison, M.
    Tsang, Y.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S2087 - S2088
  • [35] Survival outcomes in the modern era for localized pancreatic cancer with multi-agent chemotherapy and stereotactic body radiation therapy
    Sehgal, Shuchi
    Hill, Colin
    Fu Wei
    Hu Chen
    Hacker-Prietz, Amy
    Zheng Lei
    Laheru, Daniel A.
    Herman, Joseph M.
    Narang, Amol
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [36] Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy
    Rosati, L. M.
    He, J.
    Moningi, S.
    Hacker-Prietz, A.
    Huebner, T. A.
    Assadi, R. K.
    Laheru, D. A.
    Zheng, L.
    De Jesus-Acosta, A.
    Le, D. T.
    Fishman, E. K.
    Hruban, R. H.
    Hirose, K.
    Makary, M. A.
    Cameron, J. L.
    Pawlik, T. M.
    Wolfgang, C. L.
    Weiss, M. J.
    Ellsworth, S. G.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E127 - E128
  • [37] Clinical Outcomes of Stereotactic Body Radiation Therapy for Extracranial Oligometastatic Ovarian Cancer
    Mills, M.
    Reddy, A. V.
    Reshko, L. B.
    Richardson, K. M.
    Kersh, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E569 - E569
  • [38] Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer: Clinical Outcomes and Toxicity
    Reddy, Abhinav V.
    Mills, Matthew N.
    Reshko, Leonid B.
    Martin Richardson, K.
    Kersh, Charles R.
    CANCER INVESTIGATION, 2020, 38 (8-9) : 522 - 530
  • [39] Oligometastatic prostate cancer: outcomes and toxicity of stereotactic body radiation therapy (SBRT)
    Gomis Selles, E.
    Munoz Munoz, O.
    Cabrera Roldan, P.
    Delgado Leon, B. D.
    Lopez Guerra, J. L.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1276 - S1278
  • [40] Does stereotactic body radiation improve outcomes compared to conventional radiation for liver cancer patients
    Lock, Michael
    Chow, Ronald
    Jayatilaka, Aruni
    Plotnick, Meghan
    Stephens, Robert
    Nguyen, Timothy
    Fisher, Barbara
    Wong, Eugene
    Gaede, Stewart
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 35 : 17 - 20
12345